Dudediligence.

MAIA Biotechnology, Inc

MAIAAMEX · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$2.7MSep ’24−$3.6MDec ’24−$4.5MMar ’25−$5.3MJun ’25−$8.9MSep ’25−$3.6MDec ’25−$6.4MMar ’26−$7.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$0.00$0.00$0.00none on file
Operating income−$7.8M−$16.2M−$20.2M−$17.0M−$24.3M
Net income−$12.6M−$15.8M−$19.8M−$23.3M−$22.4M
Operating cash flow−$4.1M−$12.1M−$13.1M−$15.7M−$18.8M
Cash$10.6M$11.0M$7.2M$9.6M$0.00
Shares outstanding7.6M11.0M17.0M26.2M38.6M